In the first cohort of the ongoing Phase 1/2 clinical trial, the first 5 patients to complete protocol-defined islet transplants achieved insulin-independence for ongoing periods of 6 to 38 months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback